Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future.

Godman B, Haque M, McKimm J, Abu Bakar M, Sneddon J, Wale J, Campbell S, Martin AP, Hoxha I, Abilova V, Anand Paramadhas BD, Mpinda-Joseph P, Matome M, de Lemos LLP, Sefah I, Kurdi A, Opanga S, Jakupi A, Saleem Z, Hassali MA, Kibuule D, Fadare J, Bochenek T, Rothe C, Furst J, Markovic-Pekovic V, Bojanić L, Schellack N, Meyer JC, Matsebula Z, Phuong TNT, Thanh BN, Jan S, Kalungia A, Mtapuri-Zinyowera S, Sartelli M, Hill R.

Curr Med Res Opin. 2020 Feb;36(2):301-327. doi: 10.1080/03007995.2019.1700947. Epub 2019 Dec 30.

PMID:
31794332
2.

Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries.

Godman B, Grobler C, Van-De-Lisle M, Wale J, Barbosa WB, Massele A, Opondo P, Petrova G, Tachkov K, Sefah I, Abdulsalim S, Alrasheedy AA, Unnikrishnan MK, Garuoliene K, Bamitale K, Kibuule D, Kalemeera F, Fadare J, Khan TA, Hussain S, Bochenek T, Kalungia AC, Mwanza J, Martin AP, Hill R, Barbui C.

Expert Opin Pharmacother. 2019 Dec;20(18):2237-2255. doi: 10.1080/14656566.2019.1684473. Review.

PMID:
31762343
3.

The time for emergency department opioid agonist therapy is now: "A BC perspective".

Kestler A, Wale J, Allan M.

CJEM. 2019 Jul;21(4):443-445. doi: 10.1017/cem.2019.368. No abstract available.

PMID:
31333150
4.

When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit.

Denny KJ, De Wale J, Laupland KB, Harris PNA, Lipman J.

Clin Microbiol Infect. 2020 Jan;26(1):35-40. doi: 10.1016/j.cmi.2019.07.007. Epub 2019 Jul 12. Review. Erratum in: Clin Microbiol Infect. 2020 Jan 19;:.

PMID:
31306790
5.

Sterilisations at delivery or after childbirth: Addressing continuing abuses in the consent process.

Rowlands S, Wale J.

Glob Public Health. 2019 Aug;14(8):1153-1166. doi: 10.1080/17441692.2019.1583265. Epub 2019 Feb 27.

PMID:
30810486
6.

A novel approach to offering additional genomic findings-A protocol to test a two-step approach in the healthcare system.

Martyn M, Kanga-Parabia A, Lynch E, James PA, Macciocca I, Trainer AH, Halliday J, Keogh L, Wale J, Winship I, Bogwitz M, Valente G, Walsh M, Downie L, Amor D, Wallis M, Cunningham F, Burgess M, Brown NJ, Jarmolowicz A, Lunke S, Goranitis I; Melbourne Genomics Health Alliance, Gaff CL.

J Genet Couns. 2019 Apr;28(2):388-397. doi: 10.1002/jgc4.1102. Epub 2019 Feb 18.

PMID:
30776170
7.

Strengthening international patient advocacy perspectives on patient involvement in HTA within the HTAi Patient and Citizen Involvement Interest Group - Commentary.

Wale JL, Scott AM, Bertelsen N, Meade N; HTAi Patient and Citizen Involvement in HTA Interest Group (PCIG).

Res Involv Engagem. 2017 Jan 10;3:3. doi: 10.1186/s40900-016-0053-8. eCollection 2017.

8.

Patient advocate perspectives on involvement in HTA: an international snapshot.

Scott AM, Wale JL; HTAi Patient and Citizen Involvement in HTA Interest Group, Patient Involvement and Education Working Group.

Res Involv Engagem. 2017 Jan 10;3:2. doi: 10.1186/s40900-016-0052-9. eCollection 2017.

9.

The Right to Know and the Right Not to Know Revisited: Part One.

Brownsword R, Wale J.

Asian Bioeth Rev. 2017;9(1):3-18. doi: 10.1007/s41649-017-0012-1. Epub 2017 Jul 13.

10.

WHY PATIENTS SHOULD BE INVOLVED IN HEALTH TECHNOLOGY ASSESSMENT.

Wale J, Scott AM, Hofmann B, Garner S, Low E, Sansom L.

Int J Technol Assess Health Care. 2017 Jan;33(1):1-4. doi: 10.1017/S0266462317000241. Epub 2017 May 22.

PMID:
28528585
11.

Moving beyond the rhetoric of patient input in health technology assessment deliberations.

Wortley S, Wale J, Grainger D, Murphy P.

Aust Health Rev. 2017 May;41(2):170-172. doi: 10.1071/AH15216.

PMID:
27224935
12.
13.

Physicians Can Fire Patients, Too!

Wale JA.

Del Med J. 2015 Jun;87(6):186-8. No abstract available.

PMID:
26189277
14.

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

Godman B, Malmström RE, Diogene E, Gray A, Jayathissa S, Timoney A, Acurcio F, Alkan A, Brzezinska A, Bucsics A, Campbell SM, Czeczot J, de Bruyn W, Eriksson I, Yusof FA, Finlayson AE, Fürst J, Garuoliene K, Guerra Júnior A, Gulbinovič J, Jan S, Joppi R, Kalaba M, Magnisson E, McCullagh L, Miikkulainen K, Ofierska-Sujkowska G, Pedersen HB, Selke G, Sermet C, Spillane S, Supian A, Truter I, Vlahović-Palčevski V, Vien LE, Vural EH, Wale J, Władysiuk M, Zeng W, Gustafsson LL.

Expert Rev Clin Pharmacol. 2015 Jan;8(1):77-94. doi: 10.1586/17512433.2015.990380. Review.

15.

A call for action to improve access to care and treatment for patients with rare diseases in the Asia-Pacific region.

Soon SS, Lopes G, Lim HY, Wong-Rieger D, Bahri S, Hickinbotham L, Jha A, Ko BS, MacDonell D, Pwu JR, Shih R, Sirachainan E, Suh DC, Wale J, Zhang X, Wee HL.

Orphanet J Rare Dis. 2014 Sep 16;9:137. doi: 10.1186/s13023-014-0137-1.

16.

Exploring key topics in palliative care: pain and palliative care for older people.

Wale J.

Clin Med (Lond). 2014 Aug;14(4):416-8. doi: 10.7861/clinmedicine.14-4-416. No abstract available.

17.

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.

Godman B, Malmström RE, Diogene E, Jayathissa S, McTaggart S, Cars T, Alvarez-Madrazo S, Baumgärtel C, Brzezinska A, Bucsics A, Campbell S, Eriksson I, Finlayson A, Fürst J, Garuoliene K, Gutiérrez-Ibarluzea I, Hviding K, Herholz H, Joppi R, Kalaba M, Laius O, Malinowska K, Pedersen HB, Markovic-Pekovic V, Piessnegger J, Selke G, Sermet C, Spillane S, Tomek D, Vončina L, Vlahović-Palčevski V, Wale J, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL.

Front Pharmacol. 2014 Jun 10;5:109. doi: 10.3389/fphar.2014.00109. eCollection 2014. Review.

18.

An analysis of knowledge and attitudes of hospice staff towards organ and tissue donation.

Wale J, Arthur A, Faull C.

BMJ Support Palliat Care. 2014 Mar;4(1):98-103. doi: 10.1136/bmjspcare-2012-000416. Epub 2013 Apr 19.

PMID:
24644781
19.

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

Malmström RE, Godman BB, Diogene E, Baumgärtel C, Bennie M, Bishop I, Brzezinska A, Bucsics A, Campbell S, Ferrario A, Finlayson AE, Fürst J, Garuoliene K, Gomes M, Gutiérrez-Ibarluzea I, Haycox A, Hviding K, Herholz H, Hoffmann M, Jan S, Jones J, Joppi R, Kalaba M, Kvalheim C, Laius O, Langner I, Lonsdale J, Lööv SÄ, Malinowska K, McCullagh L, Paterson K, Markovic-Pekovic V, Martin A, Piessnegger J, Selke G, Sermet C, Simoens S, Tulunay C, Tomek D, Vončina L, Vlahovic-Palcevski V, Wale J, Wilcock M, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL.

Front Pharmacol. 2013 May 14;4:39. doi: 10.3389/fphar.2013.00039. eCollection 2013.

20.

A community education initiative to improve using online health information: participation and impact.

Gray K, Elliott K, Wale J.

Inform Health Soc Care. 2013 Sep;38(3):171-81. doi: 10.3109/17538157.2012.705201. Epub 2013 Jan 16.

PMID:
23324099
21.

The ASTUTE Health study protocol: deliberative stakeholder engagements to inform implementation approaches to healthcare disinvestment.

Watt AM, Hiller JE, Braunack-Mayer AJ, Moss JR, Buchan H, Wale J, Riitano DE, Hodgetts K, Street JM, Elshaug AG; ASTUTE Health Study Group.

Implement Sci. 2012 Oct 22;7:101. doi: 10.1186/1748-5908-7-101.

22.

The Cochrane Library review titles that are important to users of health care, a Cochrane Consumer Network project.

Wale JL, Belizán M, Nadel J, Jeffrey C, Vij SL.

Health Expect. 2013 Dec;16(4):e146-63. doi: 10.1111/j.1369-7625.2011.00723.x. Epub 2011 Sep 6.

24.

Elemental mercury poisoning caused by subcutaneous and intravenous injection: An unusual self-injury.

Wale J, Yadav PK, Garg S.

Indian J Radiol Imaging. 2010 May;20(2):147-9. doi: 10.4103/0971-3026.63056.

25.

International health consumers in the Cochrane Collaboration: fifteen years on.

Wale J, Colombo C, Belizan M, Nadel J.

J Ambul Care Manage. 2010 Jul-Sep;33(3):182-9. doi: 10.1097/JAC.0b013e3181e62c15.

PMID:
20539144
26.

Maternal and child health research focusing on interventions that involve consumer participation.

Belizán JM, Belizán M, Mazzoni A, Cafferata ML, Wale J, Jeffrey C, Vij S.

Int J Gynaecol Obstet. 2010 Feb;108(2):154-5. doi: 10.1016/j.ijgo.2009.09.013. Epub 2009 Nov 4. No abstract available.

PMID:
19892336
27.

Responsiveness of the Effective Consumer Scale (EC-17).

Santesso N, Rader T, Wells GA, O'Connor AM, Brooks PM, Driedger M, Gallois C, Kristjansson E, Lyddiatt A, O'Leary G, Prince M, Stacey D, Wale J, Welch V, Wilson AJ, Tugwell PS.

J Rheumatol. 2009 Sep;36(9):2087-91. doi: 10.3899/jrheum.090363.

PMID:
19738218
28.

Response to 'A survey of suppression of public health information by Australian governments'.

McKenzie A, Wale J, McLure K, Hill I, Rumley H, Colbung M, Daniels B, Powell L, Cuesta-Briand B.

Aust N Z J Public Health. 2008 Feb;32(1):90. doi: 10.1111/j.1753-6405.2008.00171.x. No abstract available.

PMID:
18290925
29.

Development of the effective musculoskeletal consumer scale.

Kristjansson E, Tugwell PS, Wilson AJ, Brooks PM, Driedger SM, Gallois C, O'Connor AM, Qualman A, Santesso N, Wale J, Wells GA.

J Rheumatol. 2007 Jun;34(6):1392-400.

PMID:
17552066
30.

Assisted dying.

Wale J, McLoughlin C, Morrison H.

Clin Med (Lond). 2006 May-Jun;6(3):318-9. No abstract available.

PMID:
16826872
31.

Attributes and skills of an effective musculoskeletal consumer.

Tugwell PS, Wilson AJ, Brooks PM, Driedger SM, Gallois C, O'Connor AM, Qualman A, Santesso N, Wale J, Wells GA.

J Rheumatol. 2005 Nov;32(11):2257-61.

PMID:
16265713
32.

Incorporating the patient perspective into outcome assessment in rheumatoid arthritis--progress at OMERACT 7.

Kirwan JR, Hewlett SE, Heiberg T, Hughes RA, Carr M, Hehir M, Kvien TK, Minnock P, Newman SP, Quest EM, Taal E, Wale J.

J Rheumatol. 2005 Nov;32(11):2250-6.

PMID:
16265712
34.

Something of value: the introduction of contingency management interventions into the New York City Health and Hospital Addiction Treatment Service.

Kellogg SH, Burns M, Coleman P, Stitzer M, Wale JB, Kreek MJ.

J Subst Abuse Treat. 2005 Jan;28(1):57-65.

PMID:
15723733
35.

Differential effects of nitric oxide synthase inhibitors in an in vivo allergic rat model.

Tulić MK, Wale JL, Holt PG, Sly PD.

Eur Respir J. 2000 May;15(5):870-7.

36.

Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide.

Tulić MK, Wale JL, Holt PG, Sly PD.

Am J Respir Cell Mol Biol. 2000 May;22(5):604-12.

PMID:
10783133
37.

Effects of salbutamol and Ro-20-1724 on airway and parenchymal mechanics in rats.

Peták F, Wale JL, Sly PD.

J Appl Physiol (1985). 1999 Oct;87(4):1373-80.

38.
39.

Sleep apnoea related hypoxia is associated with cognitive disturbances in patients with tetraplegia.

Sajkov D, Marshall R, Walker P, Mykytyn I, McEvoy RD, Wale J, Flavell H, Thornton AT, Antic R.

Spinal Cord. 1998 Apr;36(4):231-9.

PMID:
9589522
40.

Pirenzepine blunts the pulmonary parenchymal response to inhaled methacholine.

Sly PD, Willet KE, Kano S, Lanteri CJ, Wale J.

Pulm Pharmacol. 1995 Apr-Jun;8(2-3):123-9.

PMID:
8820251
41.

The effect of illness duration on perceptual asymmetry in schizophrenia.

Carr V, Wale J, Dewis S, Stephan L.

Schizophr Res. 1992 Sep;7(3):211-6.

PMID:
1356424
42.
43.
44.
45.

Antibody response to outer-membrane antigens of Pseudomonas aeruginosa in human burn wound infection.

Ward KH, Anwar H, Brown RW, Wale J, Gowar J.

J Med Microbiol. 1988 Nov;27(3):179-90.

PMID:
3143013
46.

The pharmacology of epanolol (ICI 141292)--a new beta 1-selective adrenoceptor partial agonist.

Bilski AJ, Hadfield SE, Wale JL.

J Cardiovasc Pharmacol. 1988 Aug;12(2):227-32.

PMID:
2459554
47.
48.

Schizophrenia: an information processing model.

Carr V, Wale J.

Aust N Z J Psychiatry. 1986 Jun;20(2):136-55.

PMID:
3464263
50.

Classification of beta-adrenoceptors in human isolated bronchus.

Goldie RG, Paterson JW, Spina D, Wale JL.

Br J Pharmacol. 1984 Apr;81(4):611-5.

Supplemental Content

Support Center